Literature DB >> 20921221

Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handling.

Megha A Nagle1, David M Truong, Ankur V Dnyanmote, Sun-Young Ahn, Satish A Eraly, Wei Wu, Sanjay K Nigam.   

Abstract

The organic anion transporters OAT1 (SLC22A6, originally identified by us as NKT) and OAT3 (SLC22A8) are critical for handling many toxins, metabolites, and drugs, including antivirals (Truong, D. M., Kaler, G., Khandelwal, A., Swaan, P. W., and Nigam, S. K. (2008) J. Biol. Chem. 283, 8654-8663). Although microinjected Xenopus oocytes and/or transfected cells indicate overlapping specificities, the individual contributions of these transporters in the three-dimensional context of the tissues in which they normally function remain unclear. Here, handling of HIV antivirals (stavudine, tenofovir, lamivudine, acyclovir, and zidovudine) was analyzed with three-dimensional ex vivo functional assays using knock-out tissue. To investigate the contribution of OAT1 and OAT3 in various nephron segments, the OAT-selective fluorescent tracer substrates 5-carboxyfluorescein and 6-carboxyfluorescein were used. Although OAT1 function (uptake in oat3(-/-) tissue) was confined to portions of the cortex, consistent with a proximal tubular localization, OAT3 function (uptake in oat1(-/-) tissue) was apparent throughout the cortex, indicating localization in the distal as well as proximal nephron. This functional localization indicates a complex three-dimensional context, which needs to be considered for metabolites, toxins, and drugs (e.g. antivirals) handled by both transporters. These results also raise the possibility of functional differences in the relative importance of OAT1 and OAT3 in antiviral handling in developing and mature tissue. Because the HIV antivirals are used in pregnant women, the results may also help in understanding how these drugs are handled by developing organs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20921221      PMCID: PMC3012981          DOI: 10.1074/jbc.M110.139949

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Tubular transporters and clearance of adefovir.

Authors:  Aude Servais; Philippe Lechat; Noël Zahr; Saik Urien; Guy Aymard; Marie Chantal Jaudon; Gilbert Deray; Corinne Isnard Bagnis
Journal:  Eur J Pharmacol       Date:  2006-05-06       Impact factor: 4.432

2.  Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.

Authors:  Gregory Kaler; David M Truong; Akash Khandelwal; Megha Nagle; Satish A Eraly; Peter W Swaan; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2007-06-05       Impact factor: 5.157

3.  [Tubular transporters OAT1 and MRP2 and clearance of adefovir].

Authors:  Aude Servais; Philippe Lechat; Noël Zahr; Saik Urien; Guy Aymard; Marie Chantal Jaudon; Gilbert Deray; Corinne Isnard Bagnis
Journal:  Nephrol Ther       Date:  2005-10-21       Impact factor: 0.722

4.  Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2).

Authors:  Yuichi Uwai; Hiroki Ida; Yoshie Tsuji; Toshiya Katsura; Ken-Ichi Inui
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

5.  Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice.

Authors:  Satish A Eraly; Volker Vallon; Duke A Vaughn; Jon A Gangoiti; Kerstin Richter; Megha Nagle; Julio C Monte; Timo Rieg; David M Truong; Jeffrey M Long; Bruce A Barshop; Gregory Kaler; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2005-12-14       Impact factor: 5.157

6.  Mechanism of active renal tubular efflux of tenofovir.

Authors:  Adrian S Ray; Tomas Cihlar; Kelly L Robinson; Leah Tong; Jennifer E Vela; Michael D Fuller; Lani M Wieman; Eugene J Eisenberg; Gerry R Rhodes
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

7.  Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination.

Authors:  David M Truong; Gregory Kaler; Akash Khandelwal; Peter W Swaan; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2008-01-03       Impact factor: 5.157

8.  Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture models.

Authors:  D H Sweet; S A Eraly; D A Vaughn; K T Bush; S K Nigam
Journal:  Kidney Int       Date:  2006-03       Impact factor: 10.612

9.  Organic anion transporter 3 contributes to the regulation of blood pressure.

Authors:  Volker Vallon; Satish A Eraly; William R Wikoff; Timo Rieg; Gregory Kaler; David M Truong; Sun-Young Ahn; Nitish R Mahapatra; Sushil K Mahata; Jon A Gangoiti; Wei Wu; Bruce A Barshop; Gary Siuzdak; Sanjay K Nigam
Journal:  J Am Soc Nephrol       Date:  2008-05-28       Impact factor: 10.121

Review 10.  Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues.

Authors:  Sanjay K Nigam; Kevin T Bush; Vibha Bhatnagar
Journal:  Nat Clin Pract Nephrol       Date:  2007-08
View more
  36 in total

Review 1.  Relationships between the renal handling of DMPS and DMSA and the renal handling of mercury.

Authors:  Rudolfs K Zalups; Christy C Bridges
Journal:  Chem Res Toxicol       Date:  2012-06-15       Impact factor: 3.739

Review 2.  The role of transporters in the toxicity of nucleoside and nucleotide analogs.

Authors:  Christopher A Koczor; Rebecca A Torres; William Lewis
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-04-18       Impact factor: 4.481

3.  Functional maturation of drug transporters in the developing, neonatal, and postnatal kidney.

Authors:  Derina E Sweeney; Volker Vallon; Timo Rieg; Wei Wu; Thomas F Gallegos; Sanjay K Nigam
Journal:  Mol Pharmacol       Date:  2011-04-14       Impact factor: 4.436

4.  Linkage of organic anion transporter-1 to metabolic pathways through integrated "omics"-driven network and functional analysis.

Authors:  Sun-Young Ahn; Neema Jamshidi; Monica L Mo; Wei Wu; Satish A Eraly; Ankur Dnyanmote; Kevin T Bush; Tom F Gallegos; Douglas H Sweet; Bernhard Ø Palsson; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2011-07-12       Impact factor: 5.157

Review 5.  The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease.

Authors:  Sanjay K Nigam
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-01-06       Impact factor: 13.820

Review 6.  The organic anion transporter (OAT) family: a systems biology perspective.

Authors:  Sanjay K Nigam; Kevin T Bush; Gleb Martovetsky; Sun-Young Ahn; Henry C Liu; Erin Richard; Vibha Bhatnagar; Wei Wu
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

7.  Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir.

Authors:  Brookie M Best; Scott L Letendre; Peter Koopmans; Steven S Rossi; David B Clifford; Ann C Collier; Benjamin B Gelman; Christina M Marra; Justin C McArthur; J Allen McCutchan; Susan Morgello; David M Simpson; Edmund V Capparelli; Ronald J Ellis; Igor Grant
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-01       Impact factor: 3.731

8.  Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach.

Authors:  Henry C Liu; Anne Goldenberg; Yuchen Chen; Christina Lun; Wei Wu; Kevin T Bush; Natasha Balac; Paul Rodriguez; Ruben Abagyan; Sanjay K Nigam
Journal:  J Pharmacol Exp Ther       Date:  2016-08-03       Impact factor: 4.030

9.  An Organic Anion Transporter 1 (OAT1)-centered Metabolic Network.

Authors:  Henry C Liu; Neema Jamshidi; Yuchen Chen; Satish A Eraly; Sai Yee Cho; Vibha Bhatnagar; Wei Wu; Kevin T Bush; Ruben Abagyan; Bernhard O Palsson; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2016-07-20       Impact factor: 5.157

10.  A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndrome.

Authors:  Amber Dahlin; Matthias Wittwer; Melanie de la Cruz; Jonathan M Woo; Rujuta Bam; Valeska Scharen-Guivel; John Flaherty; Adrian S Ray; Tomas Cihlar; Samir K Gupta; Kathleen M Giacomini
Journal:  Pharmacogenet Genomics       Date:  2015-02       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.